Literature DB >> 23867329

Characteristics of IFN-γ responses in IGRA among pulmonary TB suspects in a TB-endemic area.

Jia-Yih Feng1, Shiang-Fen Huang, Ming-Che Lee, Wen-Ying Ting, Yu-Chun Chen, Yung-Yang Lin, Yu-Chin Lee, Wei-Juin Su.   

Abstract

Although the diagnostic value of interferon-γ (IFN-γ) release assays for active tuberculosis (TB) is limited, the characteristic of non-TB-specific IFN-γ responses among TB suspects deserves further evaluation. We enrolled clinically suspected pulmonary TB (PTB) patients, and QuantiFERON-TB Gold In-Tube (QFT-GIT) was performed. The characteristics of IFN-γ responses were analyzed. Among 392 patients, active PTB patients had stronger IFN-γ responses to TB antigen (TBAg-Nil, P < 0.001) and lower responses to mitogen (Mitogen-Nil, P < 0.001). Lower body mass index (P = 0.001), without bacille Calmette-Guerin vaccination (P = 0.026), and active PTB (P = 0.011) were independent factors associated with lower non-TB-specific IFN-γ responses. Among TB suspects with higher TBAg-Nil (>1.02 U/mL) and lower Mitogen-Nil (<5.5 U/mL), 84.3% were active PTB cases. Among TB suspects with lower TBAg-Nil and higher Mitogen-Nil, only 4.7% were active PTB. The present study suggested that the possibilities of active PTB should be carefully excluded in TB suspects with stronger TB-specific and lower non-TB-specific IFN-γ responses in QFT-GIT.
© 2013.

Entities:  

Keywords:  Active pulmonary tuberculosis; IFN-γ; IGRA; QFT-GIT; TB suspects

Mesh:

Substances:

Year:  2013        PMID: 23867329     DOI: 10.1016/j.diagmicrobio.2013.05.020

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  Depressed Gamma Interferon Responses and Treatment Outcomes in Tuberculosis Patients: a Prospective Cohort Study.

Authors:  Jia-Yih Feng; Sheng-Wei Pan; Shiang-Fen Huang; Ying-Ying Chen; Yung-Yang Lin; Wei-Juin Su
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

2.  Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy.

Authors:  Der-Yuan Chen; Ju-Pi Li; Yi-Ming Chen; Tsai-Ling Liao; Hsin-Hua Chen; Chia-Wei Hsieh; Yea-Wen Yeh; Joung-Liang Lan
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

3.  Role of TREM-1 in pulmonary tuberculosis patients- analysis of serum soluble TREM-1 levels.

Authors:  Jia-Yih Feng; Wei-Juin Su; Sheng-Wei Pan; Yi-Chen Yeh; Yung-Yang Lin; Nien-Jung Chen
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

4.  Combination of Xpert MTB/RIF and TBAg/PHA Ratio for Prompt Diagnosis of Active Tuberculosis: A Two-Center Prospective Cohort Study.

Authors:  Feng Wang; Kui Liu; Jing Peng; Ying Luo; Guoxing Tang; Qun Lin; Hongyan Hou; Weiyong Liu; Jing Wang; Zemin Fang; Haobin Kuang; Ziyong Sun
Journal:  Front Med (Lausanne)       Date:  2020-04-15

5.  PD-L1 Expression in Monocytes Correlates with Bacterial Burden and Treatment Outcomes in Active Pulmonary Tuberculosis.

Authors:  Sheng-Wei Pan; Chin-Chung Shu; Jhong-Ru Huang; Chang-Ching Lee; Yen-Han Tseng; Jung-Jyh Hung; Po-Kuei Hsu; Nien-Jung Chen; Wei-Juin Su; Jia-Yih Feng; Yuh-Min Chen
Journal:  Int J Mol Sci       Date:  2022-01-30       Impact factor: 5.923

6.  Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays.

Authors:  Wenjing Xiong; Haiping Dong; Juanjuan Wang; Xiaoming Zou; Qian Wen; Wei Luo; Sudong Liu; Jianchun He; Shaoxi Cai; Li Ma
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.